Here are relevant reports on : route-optimization-market
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Aviation Analytics Market by Application (Fuel Management, Route Management, Flight Risk Management, inspection, others), End-User (MROs, Airlines, Airports, OEMs), Component, Deployment, Business Function, and - Global Forecast to 2027
The Aviation Analytics market is expected to grow from USD 2.5 billion in 2022 to USD 4.7 billion by 2027, at a compound annual growth rate (CAGR) of 13.0% during the forecast period.The Key players Oracle Corporation (US), General Electric (US), Lufthansa Technik (Germany), SAP (Germany), and IBM (US).
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031
The global human microbiome market, valued at US$0.91 billion in 2024, stood at US$1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Migraine Drugs Market by Product Type (Acute migraine treatment, Preventive migraine treatment), Route of administration (Oral, Injection, and Others), and End User (Hospital pharmacies, Retail pharmacies, Online pharmacies) - Global Forecast to 2023
The global Migrane Drugs market is expected to reach USD 3.96 billion by 2023 from USD 1.95 million in 2018, growing at a CAGR of 15.2%. Increasing awareness about novel therapies, launch of Calcitonin Gene-related Peptide (CGRP), increasing incidence of migraines and launch of new drugs are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new drugs, thus propelling the market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End user (Hospitals, Clinics) - Global Forecast to 2029
The global veterinary vaccines market, valued at US$8.93 billion in 2023, stood at US$9.39 billion in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$13.33 billion by the end of the period.. Growing awareness of animal health, along with the rising pet population and ownership, is driving the adoption of veterinary vaccines. Government efforts to improve animal health and the increasing popularity of pet insurance are also contributing to this trend.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient CAGR of 4.8% from 2025 to 2030, culminating in a forecasted valuation of US$63.66 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Data Center Infrastructure Management Market by DCIM Software (Monitoring, Operations & Management) and Functionality (Asset Management, Operational Monitoring, Performance Optimization, Configuration, Reporting & Dashboards) - Global Forecast to 2029
The data center infrastructure management (DCIM) market is projected to reach USD 5.01 billion by 2029 at a compound annual growth rate (CAGR) of 10.6% during the forecast period. Some of the key players operating in the Data Center Infrastructure Management Market are – Schneider Electric (France), Vertiv (US), Johnson Controls (US), Eaton (US), Delta Electronics (Taiwan), Huawei (China), ABB (Switzerland), Rittal (Germany), FNT Software (Germany), Nlyte Software (US), Franklin Electric (US).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Content Delivery Network Market by Component (Solutions (Web Performance Optimization, Media Delivery, Cloud Security) and Services), Content Type (Static and Dynamic), Provider Type, Application Area and Region - Global Forecast to 2028
The content delivery network market size is projected to reach USD 36.5 billion by 2028, at a CAGR of 10.9% during the forecast period. The major vendors covered in the content delivery network market include Akamai Technologies (US), Microsoft (US), IBM (US), Edgio (US), Google (US), AWS (US), AT&T (US), Cloudflare (US), Lumen Technologies (US), Deutsche Telekom (Germany), Fastly (US), Citrix systems (US), NTT Communications (Japan), Comcast Technologies (US), Rackspace Technology (US), CDNetworks (South Korea), Tata Communications (India), Imperva (US), Broadpeak (France), Quantil (US), StackPath (US), G Core Labs SA (Luxembourg), Tencent Cloud (China), OnApp Limited (UK),EVG Corp (Vietnam), Kingsoft Cloud (China), Bunny.net (Slovenia) and Baishan Cloud (US).
- Published: July 2023
- Price: $ 7150
- TOC Available:
Records 31 to 40 of 50
